TY  - JOUR
AU  - Batista-Duharte, Alexander
AU  - Hassouneh, Fakhri
AU  - Alvarez-Heredia, Pablo
AU  - Pera, Alejandra
AU  - Solana, Rafael
PY  - 2022
DO  - 10.3390/pharmaceutics14081721
SN  - 1999-4923
UR  - http://hdl.handle.net/10668/21559
T2  - Pharmaceutics
AB  - In recent years, the use of immune checkpoint inhibitors (ICIs) in combination with approved or experimental vaccines has proven to be a promising approach to improve vaccine immunogenicity and efficacy. This strategy seeks to overcome the...
LA  - en
PB  - MDPI
KW  - CTLA-4
KW  - PD-1
KW  - PD-L1
KW  - Antisense oligonucleotides
KW  - Aptamers
KW  - Immune checkpoint inhibitors
KW  - Molecular adjuvants
KW  - Monoclonal antibodies
KW  - Peptides
KW  - Vaccines
TI  - Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches.
TY  - research article
VL  - 14
ER  -